A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix
- 1 July 1988
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 159 (1) , 87-94
- https://doi.org/10.1016/0002-9378(88)90499-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Survival of nonsurgically staged patients with negative lymphangiograms who had Stage IIB carcinoma of the cervix treated by pelvic radiation plus hydroxyureaAmerican Journal of Obstetrics and Gynecology, 1985
- Hydroxyurea: A radiation potentiator in carcinoma of the uterine cervixAmerican Journal of Obstetrics and Gynecology, 1983
- Final report on the united states phase i clinical trial of the hypoxic cell radiosensitizer, misonidazole (RO-07-0582; NSC #261037)Cancer, 1981
- Radiation therapy oncology group clinical trials with misonidazoleCancer, 1981
- Hydroxy urea and radiation for stages IIIB and IVA cervix cancer analysis of recurrence patterns and radiation factorsInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Hydroxyurea or placebo combined with radiation to treat stages iiib and iv cervical cancer confined to the pelvisInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervixAmerican Journal of Obstetrics and Gynecology, 1977
- Hydroxyurea and radiation therapy in advanced cervical cancerAmerican Journal of Obstetrics and Gynecology, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958